BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22179087)

  • 1. Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism.
    Maniero C; Fassina A; Seccia TM; Toniato A; Iacobone M; Plebani M; De Caro R; Calò LA; Pessina AC; Rossi GP
    J Hypertens; 2012 Feb; 30(2):390-5. PubMed ID: 22179087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
    Tomaschitz A; Ritz E; Pieske B; Rus-Machan J; Kienreich K; Verheyen N; Gaksch M; Grübler M; Fahrleitner-Pammer A; Mrak P; Toplak H; Kraigher-Krainer E; März W; Pilz S
    Metabolism; 2014 Jan; 63(1):20-31. PubMed ID: 24095631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy.
    Lenzini L; Prisco S; Vanderriele PE; Lerco S; Torresan F; Maiolino G; Seccia TM; Iacobone M; Rossi GP
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3726-3734. PubMed ID: 30865228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP; Ragazzo F; Seccia TM; Maniero C; Barisa M; Calò LA; Frigo AC; Fassina A; Pessina AC
    Hypertension; 2012 Aug; 60(2):431-6. PubMed ID: 22733469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
    Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting parathyroid hormone levels in different types of primary aldosteronism.
    Jiang Y; Zhang C; Ye L; Su T; Zhou W; Jiang L; Zhang Y; Wang W
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):267-74. PubMed ID: 26589237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.
    Pilz S; Kienreich K; Drechsler C; Ritz E; Fahrleitner-Pammer A; Gaksch M; Meinitzer A; März W; Pieber TR; Tomaschitz A
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E75-9. PubMed ID: 22013107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral adrenalectomy improves urinary protein excretion but does not abolish its relationship to sodium excretion in patients with aldosterone-producing adenoma.
    Pimenta E; Gordon RD; Ahmed AH; Cowley D; Robson D; Kogovsek C; Stowasser M
    J Hum Hypertens; 2011 Oct; 25(10):592-9. PubMed ID: 21068764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
    Tomaschitz A; Ritz E; Pieske B; Fahrleitner-Pammer A; Kienreich K; Horina JH; Drechsler C; März W; Ofner M; Pieber TR; Pilz S
    Cardiovasc Res; 2012 Apr; 94(1):10-9. PubMed ID: 22334595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of parathyroid hormone and vitamin D in essential hypertension.
    Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
    Rossi GP; Bernini G; Caliumi C; Desideri G; Fabris B; Ferri C; Ganzaroli C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Mattarello MJ; Moretti A; Palumbo G; Parenti G; Porteri E; Semplicini A; Rizzoni D; Rossi E; Boscaro M; Pessina AC; Mantero F;
    J Am Coll Cardiol; 2006 Dec; 48(11):2293-300. PubMed ID: 17161262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems.
    Gennari C; Nami R; Gonnelli S
    Miner Electrolyte Metab; 1995; 21(1-3):77-81. PubMed ID: 7565468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas.
    Bhadada SK; Cardenas M; Bhansali A; Mittal BR; Behera A; Chanukya GV; Nahar U; Rao DS
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):382-5. PubMed ID: 18284640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
    Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
    Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensitivity.
    Nordenström E; Westerdahl J; Isaksson A; Lindblom P; Bergenfelz A
    World J Surg; 2003 Feb; 27(2):212-5. PubMed ID: 12616439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Aldosterone and Parathyroid Hormone Levels in Patients With Adrenocortical Tumors.
    Zavatta G; Di Dalmazi G; Altieri P; Pelusi C; Golfieri R; Mosconi C; Balacchi C; Borghi C; Cosentino ER; Di Cintio I; Malandra J; Pagotto U; Vicennati V
    Endocr Pract; 2022 Jan; 28(1):90-95. PubMed ID: 34508903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolongation of the QT interval in primary aldosteronism.
    Matsumura K; Fujii K; Kansui Y; Arima H; Iida M
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):66-9. PubMed ID: 15730437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.